Cargando…
Ⅰb期肺癌术后辅助化疗高风险因素分析
BACKGROUND AND OBJECTIVE: More than 35% Ib stage lung cancers have metastasised or recurrenced after operation, whose prognosis still remain poor. There're much controversy over the necessity of adjuvant chemotherapy to them. This aim of this study is investigated the clinical and pathological...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000450/ https://www.ncbi.nlm.nih.gov/pubmed/24854559 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.09 |